Compare TOP & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TOP | RXRX |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.2B |
| IPO Year | 2021 | 2021 |
| Metric | TOP | RXRX |
|---|---|---|
| Price | $15.82 | $2.48 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $6.77 |
| AVG Volume (30 Days) | 232.8K | ★ 21.1M |
| Earning Date | 07-07-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 81.25 | 14.79 |
| EPS | ★ N/A | N/A |
| Revenue | $4,723,765.00 | ★ $74,681,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $9.23 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 41.89 | 26.92 |
| 52 Week Low | $1.85 | $2.50 |
| 52 Week High | $17.99 | $5.24 |
| Indicator | TOP | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 54.21 | 30.58 |
| Support Level | $13.96 | N/A |
| Resistance Level | $16.63 | $3.66 |
| Average True Range (ATR) | 1.71 | 0.29 |
| MACD | 0.36 | -0.12 |
| Stochastic Oscillator | 71.98 | 0.31 |
TOP Financial Group Ltd is operates as an online brokerage firm in Hong Kong specializing in the trading of local and overseas equities, futures, and options products. It conduct the futures and stock brokerage business through three trading platforms, Esunny for futures trading and Longbridge for stock trading, all of which were licensed from third parties and can be easily accessed through its application, or APP, software, and websites. The three platforms are designed for seamless, efficient, and secure trading platform. The company operates and manages its business as a single operating and reportable segment.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.